World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT00669760
Date of registration: 28/04/2008
Prospective Registration: Yes
Primary sponsor: University Hospital Muenster
Public title: Dissection of Staphylococcus Aureus Infection From Colonization in Cystic Fibrosis Patients StaphCI
Scientific title: Dissection of Staphylococcus Aureus Infection From Colonization in Cystic Fibrosis Patients, a Non-interventional, Prospective, Longitudinal Multicenter Study.
Date of first enrolment: July 2008
Target sample size: 195
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00669760
Study type:  Observational
Study design:  Observational Model: Case-Only, Time Perspective: Prospective  
Phase:  N/A
Countries of recruitment
Austria Germany
Contacts
Name:     Barbara C Kahl, MD
Address: 
Telephone:
Email:
Affiliation:  Dept. Med. Microbiology, University Clinics Muenster, Germany
Key inclusion & exclusion criteria

Inclusion Criteria:

- positive S. aureus cultures for more than 6 months within the last year; children (>6
years) and patients with CF, who are able to perform lung function tests

Exclusion Criteria:

- Pseudomonas aeruginosa and/or Burkholderia cepacia colonization or infection for more
than 6 months within the last year before recruitment; patients who have not been
colonized with these pathogens before but acquire them within the study period and
are colonized/infected for more than 6 months during the observation period



Age minimum: 6 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Cystic Fibrosis
Intervention(s)
Other: non-interventional study
Primary Outcome(s)
bacterial load of sputum cultures [high (>/= 1000000CFU/ml); low (<1000000CFU/ml)] [Time Frame: 2 years]
Secondary Outcome(s)
antibody titres against S. aureus specific antigens; S100A12, IL-8, TNF-alpha, CRP [Time Frame: 2 years]
Secondary ID(s)
Muko e.V. S05/07
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Mukoviszidose eV Bonn Germany
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history